Seok-chan Kang

Title: Seok-chan Kang: Innovator in Pharmaceutical Composition

Introduction

Seok-chan Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for therapeutic use.

Latest Patents

Kang holds a patent for a pharmaceutical composition with improved stability containing a factor VII fusion protein. This invention provides a composition that includes a fusion protein comprising Factor VII (FVII) and transferrin as an active ingredient. The transferrin is linked to the C-terminus of the FVII, along with trehalose or glycine as a bulking agent. This innovative composition allows for the stable storage of FVII and its variants at room temperature for extended periods. It serves as a valuable therapeutic agent for patients suffering from hemophilia or congenital FVII deficiency.

Career Highlights

Seok-chan Kang is associated with Tiumbio Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective treatments that can significantly improve patient outcomes.

Collaborations

Kang collaborates with esteemed colleagues, including Hong-Kee Kim and Ho Chul Shin, who contribute to his research endeavors and innovations in the field.

Conclusion

Seok-chan Kang's contributions to pharmaceutical compositions highlight his dedication to improving healthcare solutions. His innovative work in developing stable therapeutic agents showcases the importance of research and collaboration in advancing medical science.